Dan Liu
- Reproductive Medicine top 10%
-
- MicroRNA in disease regulation 8
-
- Natural product bioactivities and synthesis 9
- Signaling Pathways in Disease 5
- Biotechnology top 10%
- Toxicology top 10%
-
- Spinal Dysraphism and Malformations 8
-
- Pharmacological Effects of Natural Compounds 5
-
- Folate and B Vitamins Research 5
-
- Cleft Lip and Palate Research 5
-
- Congenital Anomalies and Fetal Surgery 4
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Dan Liu
94 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 124
- Reproductive Medicine 91
- Cancer Research 149
- Molecular Biology 660
- Biotechnology 76
- Toxicology 26
Countries citing papers authored by Dan Liu
This map shows the geographic impact of Dan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Liu more than expected).
Fields of papers citing papers by Dan Liu
This network shows the impact of papers produced by Dan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Liu. The network helps show where Dan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 11 | |
| 4 | 2021 | 21 | |
| 5 | 2021 | 31 | |
| 6 | 2021 | 46 | |
| 7 | 2020 | 16 | |
| 8 | 2020 | 11 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 16 | |
| 11 | Bulbil development of Pinellia cordata. | 2018 | 1 |
| 12 | 2018 | 3 | |
| 13 | 2018 | 12 | |
| 14 | 2016 | 7 | |
| 15 | 2014 | 7 | |
| 16 | Preparation and Evaluation of Long-circulating Liposomes of Paraoxonase | 2010 | 1 |
| 17 | In vitro study of Api6 expression in lipid loading and inflammatory macrophages | 2010 | 1 |
| 18 | Optimization of Condition for Fermentation of Recombinant E. coli with Human aFGF Gene | 2009 | 1 |
| 19 | Research advance of ursolic acid | 2007 | 4 |
| 20 | Identification of polymorphic microsatellite DNA loci and paternity testing of Amur tigers | 2003 | 3 |
About Dan Liu
Dan Liu is a scholar working on Molecular Biology, Pharmacology and Cancer Research, having authored 96 papers that have together received 1.3k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (9 papers), Spinal Dysraphism and Malformations (8 papers), MicroRNA in disease regulation (8 papers), Pharmacological Effects of Natural Compounds (5 papers), Folate and B Vitamins Research (5 papers), Cleft Lip and Palate Research (5 papers), Signaling Pathways in Disease (5 papers) and Congenital Anomalies and Fetal Surgery (4 papers). The work is most often cited by research in Reproductive Medicine (91 citations), Cancer Research (149 citations) and Molecular Biology (660 citations). Dan Liu has collaborated with scholars based in China, United States and France. Frequent co-authors include Xiaowei Wei, Zhengwei Yuan, Hui Gu, Wei Ma, Nikolaï Lebovka, Eugène Vorobiev, Baishun Li, Chuan Huang, Liqing Fan and Hongchuan Nie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.